Danish biotech giant Novozymes has entered into a contract with an unnamed key player in the plant-based industry. As part of the contract, it will invest 2 billion Danish kroner into an alt-protein production line in Nebraska.
Novozymes and Chr. Hansen Merge to Form Novonesis: A Global Biosolutions Powerhouse with €3.7 Billion Annual Revenue
The world’s largest provider of microbial technologies and enzymes, Novozymes, and Chr. Hansen, a bioscience supplier, have successfully merged to form Novonesis, a global partner for multiple industries, creating biosolutions for better lives and a healthier planet. The Danish merger — reportedly the largest ever in the country — was finalized following the final registration with the Danish Business Authority. According to the announcement, the combined group will have annual revenue of approximately €3.7 billion. Novonesis brings together 10,000 people worldwide and an expertise that spans more than 30 different industries under the leadership of Ester Baiget, former CEO of Novozymes. “We have gathered the brightest minds and together with my 10,000 colleagues, we will unlock the limitless potential of biosolutions,” shared Ester Baiget, now President and CEO …